165 related articles for article (PubMed ID: 33513855)
1. Survival Analysis of 3 Different Age Groups and Prognostic Factors among 402 Patients with Skeletal High-Grade Osteosarcoma. Real World Data from a Single Tertiary Sarcoma Center.
Evenhuis RE; Acem I; Rueten-Budde AJ; Karis DSA; Fiocco M; Dorleijn DMJ; Speetjens FM; Anninga J; Gelderblom H; van de Sande MAJ
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33513855
[TBL] [Abstract][Full Text] [Related]
2. How Are Indeterminate Pulmonary Nodules at Diagnosis Associated with Survival in Patients with High-Grade Osteosarcoma?
Tsoi KM; Lowe M; Tsuda Y; Lex JR; Fujiwara T; Almeer G; Gregory J; Stevenson J; Evans SE; Botchu R; Jeys LM
Clin Orthop Relat Res; 2021 Feb; 479(2):298-308. PubMed ID: 32956141
[TBL] [Abstract][Full Text] [Related]
3. Is Microscopic Vascular Invasion in Tumor Specimens Associated with Worse Prognosis in Patients with High-grade Localized Osteosarcoma?
Tsuda Y; Tsoi K; Stevenson JD; Parry MC; Fujiwara T; Sumathi V; Jeys LM
Clin Orthop Relat Res; 2020 Jun; 478(6):1190-1198. PubMed ID: 31904683
[TBL] [Abstract][Full Text] [Related]
4. Homogenous and Heterogenous Prognostic Factors for Patients with Bone Sarcoma.
Xu G; Wu H; Xu Y; Zhang Y; Lin F; Baklaushev VP; Chekhonin VP; Peltzer K; Wang X; Mao M; Wang G; Cui P; Zhang C
Orthop Surg; 2021 Feb; 13(1):134-144. PubMed ID: 33305494
[TBL] [Abstract][Full Text] [Related]
5. A Novel System for the Surgical Staging of Primary High-grade Osteosarcoma: The Birmingham Classification.
Jeys LM; Thorne CJ; Parry M; Gaston CL; Sumathi VP; Grimer JR
Clin Orthop Relat Res; 2017 Mar; 475(3):842-850. PubMed ID: 27138473
[TBL] [Abstract][Full Text] [Related]
6. Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
Posch F; Leitner L; Bergovec M; Bezan A; Stotz M; Gerger A; Pichler M; Stöger H; Liegl-Atzwanger B; Leithner A; Szkandera J
Clin Orthop Relat Res; 2017 May; 475(5):1427-1435. PubMed ID: 28083752
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of prognostic factors in osteosarcoma adult patients, a single institution experience].
Adamkova Krakorova D; Vesely K; Zambo I; Tucek S; Tomasek J; Jureckova A; Janicek P; Cerny J; Pazourek L; Ondrusek S; Selingerova I
Klin Onkol; 2012; 25(5):346-58. PubMed ID: 23102196
[TBL] [Abstract][Full Text] [Related]
8. Analysis of prognostic factors and histopathological response to neoadjuvant chemotherapy in osteosarcoma.
Erdoğan F; Çinka H; Akman BÇ; Coşkun HS; Dabak N
Jt Dis Relat Surg; 2023; 34(1):196-206. PubMed ID: 36700283
[TBL] [Abstract][Full Text] [Related]
9. Tumor grade and symptoms at presentation are survival risk factors in Chinese patients with primary retroperitoneal sarcoma.
Zhuang A; Fang Y; Heger M; Ma L; Xu J; Wang J; Lu W; Tong H; Zhou Y; Zhang Y
J Clin Transl Res; 2022 Dec; 8(6):584-593. PubMed ID: 36683651
[TBL] [Abstract][Full Text] [Related]
10. Osteosarcoma with metastasis at initial diagnosis: Current outcomes and prognostic factors in the context of a comprehensive cancer center.
Salah S; Ahmad R; Sultan I; Yaser S; Shehadeh A
Mol Clin Oncol; 2014 Sep; 2(5):811-816. PubMed ID: 25054050
[TBL] [Abstract][Full Text] [Related]
11. The importance of standardized treatment in high-grade osteosarcoma: 30 years of experience from a hospital-based database.
Aggerholm-Pedersen N; Maretty-Nielsen K; Keller J; Baerentzen S; Schrøder H; Jørgensen PH; Hansen BH; Nielsen OS; Safwat A
Acta Oncol; 2015 Jan; 54(1):17-24. PubMed ID: 24960582
[TBL] [Abstract][Full Text] [Related]
12. Impact of chemotherapy-induced necrosis on event-free and overall survival after preoperative MAP chemotherapy in patients with primary high-grade localized osteosarcoma.
Tsuda Y; Tsoi K; Parry MC; Stevenson JD; Fujiwara T; Sumathi V; Jeys LM
Bone Joint J; 2020 Jun; 102-B(6):795-803. PubMed ID: 32475245
[TBL] [Abstract][Full Text] [Related]
13. Influence of age and subtype in outcome of operable liposarcoma.
Greto D; Saieva C; Loi M; Terziani F; Visani L; Garlatti P; Lo Russo M; Muntoni C; Becherini C; Topulli J; Campanacci D; Beltrami G; Scoccianti G; Muratori F; Bonomo P; Desideri I; Francolini G; Livi L
Radiol Med; 2019 Apr; 124(4):290-300. PubMed ID: 30421387
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.
Bacci G; Longhi A; Versari M; Mercuri M; Briccoli A; Picci P
Cancer; 2006 Mar; 106(5):1154-61. PubMed ID: 16421923
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant Chemotherapy Followed by Delayed Surgery: Is it Necessary for All Patients With Nonmetastatic High-Grade Pelvic Osteosarcoma?
Xu J; Xie L; Guo W
Clin Orthop Relat Res; 2018 Nov; 476(11):2177-2186. PubMed ID: 29912746
[TBL] [Abstract][Full Text] [Related]
16. Developing a prognostic model for patients with localized osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate: A single-center experience of 237 patients.
Nataraj V; Batra A; Rastogi S; Khan SA; Sharma MC; Vishnubhatla S; Bakhshi S
J Surg Oncol; 2015 Nov; 112(6):662-8. PubMed ID: 26381138
[TBL] [Abstract][Full Text] [Related]
17. Tumor-associated mortality and prognostic factors in myxofibrosarcoma - A retrospective review of 109 patients.
Gilg MM; Sunitsch S; Leitner L; Bergovec M; Szkandera J; Leithner A; Liegl-Atzwanger B
Orthop Traumatol Surg Res; 2020 Oct; 106(6):1059-1065. PubMed ID: 32778437
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Factors for Survival in Patients With High-grade Chondrosarcoma.
Kinoshita H; Kamoda H; Hagiwara Y; Kinoshita S; Ohtori S; Yonemoto T
Cancer Diagn Progn; 2022; 2(6):681-685. PubMed ID: 36340450
[TBL] [Abstract][Full Text] [Related]
19. Surgery in reference centers improves survival of sarcoma patients: a nationwide study.
Blay JY; Honoré C; Stoeckle E; Meeus P; Jafari M; Gouin F; Anract P; Ferron G; Rochwerger A; Ropars M; Carrere S; Marchal F; Sirveaux F; Di Marco A; Le Nail LR; Guiramand J; Vaz G; Machiavello JC; Marco O; Causeret S; Gimbergues P; Fiorenza F; Chaigneau L; Guillemin F; Guilloit JM; Dujardin F; Spano JP; Ruzic JC; Michot A; Soibinet P; Bompas E; Chevreau C; Duffaud F; Rios M; Perrin C; Firmin N; Bertucci F; Le Pechoux C; Le Loarer F; Collard O; Karanian-Philippe M; Brahmi M; Dufresne A; Dupré A; Ducimetière F; Giraud A; Pérol D; Toulmonde M; Ray-Coquard I; Italiano A; Le Cesne A; Penel N; Bonvalot S;
Ann Oncol; 2019 Jul; 30(7):1143-1153. PubMed ID: 31081028
[TBL] [Abstract][Full Text] [Related]
20. Bone sarcoma follow-up; a nationwide analysis of oncological events after initial treatment.
Goedhart LM; Ho VKY; Ploegmakers JJW; van der Geest ICM; van de Sande MAJ; Bramer JA; Stevens M; Jutte PC
J Bone Oncol; 2023 Feb; 38():100466. PubMed ID: 36578650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
